Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
2'3'-cGAMP (Sodium Salt): Unraveling Macrophage Polarization
2026-06-15
Explore the advanced role of 2'3'-cGAMP (sodium salt) in driving macrophage polarization and boosting phagocytosis for next-generation immunotherapy. This in-depth analysis highlights novel mechanistic insights and practical assay strategies, setting it apart from prior content.
-
D2HG Biosensors Reveal STING-Induced Metabolic Shifts in Imm
2026-06-15
Wang et al. (2025) developed genetically encoded D-2-hydroxyglutarate (D2HG) biosensors based on the structural mechanism of DhdR regulation, enabling real-time quantification of D2HG in living cells. Their work uncovers metabolic crosstalk between STING pathway activation and D2HG production, offering new tools and perspectives for dissecting immunometabolic regulation.
-
Mavorixafor in WHIM Syndrome: Phase 3 Clinical and Mechanist
2026-06-14
A recent phase 3 trial demonstrates that mavorixafor, an oral CXCR4 antagonist, significantly increases neutrophil and lymphocyte counts and reduces infections in WHIM syndrome patients. This represents a substantial advance over previous symptomatic therapies, highlighting mechanistic correction of the underlying CXCR4 signaling defect and setting a new standard for rare immunodeficiency management.
-
Stabilizing RNA Lipid Nanoparticles for Nebulized Pulmonary
2026-06-13
The referenced study demonstrates a buffer-based strategy for stabilizing RNA lipid nanoparticles (LNPs) during nebulization, crucial for efficient pulmonary mRNA and siRNA delivery. This approach maintains nanoparticle integrity and bioactivity, offering a generalizable method for advancing inhaled RNA therapeutics.
-
Chlorpromazine HCl: Host-Directed Antibacterial Mechanisms
2026-06-12
Explore how Chlorpromazine HCl, a dopamine receptor antagonist, enables host-directed antibacterial strategies by activating macrophage defense pathways. This article delivers a unique focus on innate immunity and translational research applications.
-
Carbapenemase Gene Transmission in Enterobacter cloacae: Ins
2026-06-12
This study systematically characterizes the prevalence, genetic locations, and transmission dynamics of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China. Key findings reveal the predominant role of plasmid-mediated blaNDM-1 dissemination and high multidrug resistance, informing future antimicrobial resistance research and surveillance strategies.
-
Vidarabine Monohydrate: Antiviral Mechanism and Research Uti
2026-06-11
Vidarabine monohydrate, also known as Spongoadenosine monohydrate, is a high-purity nucleoside analog used as an antiviral research compound. Its primary mechanism is the inhibition of viral DNA synthesis, with proven DMSO solubility and robust selectivity for DNA virus studies. The compound is supported by stringent protocol parameters and clear storage guidelines for reproducible results.
-
2'3'-cGAMP (Sodium Salt): Precision Tool for STING Pathway R
2026-06-11
2'3'-cGAMP (sodium salt) from APExBIO delivers unmatched sensitivity for dissecting cGAS-STING signaling and type I interferon induction. This article unpacks advanced workflows, practical troubleshooting, and translational innovations, including integration with the latest cervical cancer research.
-
PPACK Dihydrochloride: Precise Thrombin Inhibition in Platel
2026-06-10
PPACK Dihydrochloride delivers high-affinity, irreversible thrombin inhibition for dissecting the thrombin signaling pathway in blood coagulation research. This article details protocol parameters, advanced workflow enhancements, and troubleshooting strategies to maximize specificity and reproducibility using APExBIO's trusted reagent.
-
2-NBDG in Neurodegeneration: Illuminating Glucose Metabolism
2026-06-10
Explore how 2-NBDG enables real-time, quantitative analysis of neuronal glucose metabolism, revealing critical pathways in tauopathies and neurodegeneration. Discover unique protocol insights and translational applications of this fluorescent glucose analog.
-
Reelin-SFK Signaling Prerequisite for Ketamine’s Antidepress
2026-06-09
This study uncovers that intact synaptic Reelin signaling via Apoer2 and Src family kinases is essential for ketamine-induced synaptic plasticity and behavioral responses in the hippocampus. Disruptions in this pathway may explain nonresponsiveness to ketamine in treatment-resistant depression, highlighting a mechanistic basis for future therapeutic strategies.
-
Palmitic acid (Hexadecanoic Acid): Technical Guide and Proto
2026-06-09
Palmitic acid (SKU N2456) provides a high-purity, well-characterized saturated long-chain fatty acid for researchers studying lipid metabolism, protein palmitoylation, and metabolic disorder pathways. It is not suitable for protocols requiring aqueous solubility or long-term solution stability, making strict adherence to reconstitution and storage protocols essential.
-
Lambda Protein Phosphatase (RNase-free): Precision Dephospho
2026-06-08
Unlock the power of Lambda Protein Phosphatase for advanced study of protein phosphorylation and circadian biology. Discover how this Mn²⁺-dependent enzyme enables precise validation of phosphorylation sites and antibody specificity, with expert guidance on protocol optimization and scientific insights from recent research.
-
Betaine Hydrochloride: Advanced Workflows in Enzyme Research
2026-06-08
Betaine hydrochloride empowers researchers with high solubility and reproducibility for metabolic enzyme and protease assays. Explore protocol refinements, troubleshooting guidance, and the translational impact of integrating this water-soluble betaine derivative into modern biochemical workflows.
-
Translating BTK Inhibition: Ibrutinib's Mechanistic Power in
2026-06-07
Explore the mechanistic depth and translational strategies enabled by Ibrutinib (PCI-32765), a selective Bruton’s Tyrosine Kinase inhibitor. This article bridges advanced biological rationale, optimized protocols, and actionable insights for researchers targeting B-cell pathobiology in malignancy and autoimmunity, while highlighting competitive differentiation and future outlooks.